Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 13 Cisplatin 12 Carboplatin 12 Drug Therapy 10 Gemcitabine 8 Gefitinib 8 Docetaxel 8 camrelizumab 5 apatinib 5 Radiotherapy 5 Paclitaxel 5 Nivolumab 5 Irinotecan 5 Erlotinib Hydrochloride 5 Endostatins 5 tislelizumab 4 pembrolizumab 4 endostar protein 4 Simvastatin 4 Bevacizumab 4 anlotinib 3 Platinum Compounds 3 Immune Checkpoint Inhibitors 3 Etoposide 3 toripalimab 2 surufatinib 2 olaparib 2 durvalumab 2 atezolizumab 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Glucose × Thoracic × Clear all

NCT01836575 2013-04-22

PS2

Instituto Nacional de Cancer, Brazil

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡